(Reuters) - Japanese drugmaker Otsuka Holdings Co will buy Astex Pharmaceuticals Inc for about 90 billion yen ($900 million) to tap the cancer drugs the U.S. company is developing, the Nikkei business daily said. (http://link.reuters.com/hed82v) Otsuka said in a stock exchange statement that nothing had been decided on the matter at this time and that it would make an announcement of any formal decisions. An Otsuka spokeswoman declined to comment on whether the company was in talks to purchase Astex. Shares of Astex, which had a market capitalization of $634. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment